
NYSEHealthcareMedical - Instruments & Supplies
أحدث البيانات المتاحة
223.39 US$
−2.595 US$ · -1.15%
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
جلسة التداول العادية
223.39 US$
−2.595 US$ · -1.15%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
نطاق اليوم
السعر الحالي 223.39 US$
نطاق 52 أسبوعًا
السعر الحالي 223.39 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
99
قيمة جذابة جدًا
المشاعر
72
صعودي
المخاطر
43
مخاطر أعلى من المعتاد
الزخم
40
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
نطاق اليوم
السعر الحالي 223.39 US$
نطاق 52 أسبوعًا
السعر الحالي 223.39 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 5.65 مليار USD | 5.15 مليار USD | 4.69 مليار USD | 4.22 مليار USD | 3.58 مليار USD |
| تكلفة البضاعة المباعة | 2.2 مليار USD | 2.09 مليار USD | 2.03 مليار USD | 1.87 مليار USD | 1.55 مليار USD |
| الربح الإجمالي | 3.45 مليار USD | 3.05 مليار USD | 2.66 مليار USD | 2.36 مليار USD | 2.02 مليار USD |
| البحث والتطوير | 378.29 مليون USD | 331.28 مليون USD | 307.53 مليون USD | 287.64 مليون USD | 253.58 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 1.12 مليار USD | 991.02 مليون USD | 917.14 مليون USD | 874 مليون USD | 739.37 مليون USD |
| نفقات التشغيل | 1.54 مليار USD | 1.37 مليار USD | 1.34 مليار USD | 1.22 مليار USD | 1.02 مليار USD |
| مصاريف الفوائد | — | 12.61 مليون USD | 45.71 مليون USD | 47.38 مليون USD | 22.31 مليون USD |
| الاستهلاك والإطفاء | 244.15 مليون USD | 235.81 مليون USD | 216.21 مليون USD | 197.56 مليون USD | 193.84 مليون USD |
| الدخل التشغيلي | 1.91 مليار USD | 1.69 مليار USD | 1.32 مليار USD | 1.13 مليار USD | 1 مليار USD |
| صافي الدخل | 1.52 مليار USD | 1.4 مليار USD | 1.02 مليار USD | 897.56 مليون USD | 779.44 مليون USD |
تم تحديث حقائق الشركة 8 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
242.7 US$
ارتفاع محتمل بنسبة 8.65%| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 31 أغسطس 2010 | 2:1 | — | — |
تقسيم الأسهم | 3 أكتوبر 2005 | 2:1 | — | — |
تقسيم الأسهم | 3 أبريل 2000 | 2:1 | — | — |
تقسيم الأسهم | 17 نوفمبر 1998 | 2:1 | — | — |
ساري 31 أغسطس 2010
2:1
ساري 3 أكتوبر 2005
2:1
ساري 3 أبريل 2000
2:1
ساري 17 نوفمبر 1998
2:1
صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T61.21 مليار0.05%129.41 ترليون JPY0.09%122,700 JP¥-0.57%
Vanguard Morningstar Total Stock Market ETFVTI1.11 مليار0.05%2.3 ترليون USD0.03%379.98 US$-0.28%
Vanguard S&P 500 ETFVOO925.27 مليون0.05%1.8 ترليون USD0.03%712.7 US$-0.23%
Vanguard Morningstar Mid-Cap ETFVO753.35 مليون0.33%226.4 مليار USD0.03%80.03 US$-0.14%
Vanguard Morningstar Growth ETFVUG444.29 مليون0.12%384.6 مليار USD0.03%92.14 US$-0.30%
iShares Core S&P 500 ETFIVV433.79 مليون0.05%899.63 مليار USD0.03%778.74 US$-0.24%
State Street SPDR S&P 500 ETFSPY386.52 مليون0.05%819.04 مليار USD0.09%775.32 US$-0.24%
First Trust Rising Dividend Achievers ETFRDVY362.59 مليون1.43%25.37 مليار USD0.47%78.76 US$-0.14%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Vanguard Morningstar Growth ETFVUG
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
First Trust Rising Dividend Achievers ETFRDVYالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.